<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rsts" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rsts</book-part-id>
      <title-group>
        <title>Rubinstein-Taybi Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Broad Thumbs-Hallux Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stevens</surname>
            <given-names>Cathy A</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Medical Genetics<break/>Professor, Pediatrics<break/>University of Tennessee College of Medicine<break/>Chattanooga, Tennessee</aff>
          <email>cathy.stevens@erlanger.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2002-08-30" date-type="created">
          <day>30</day>
          <month>8</month>
          <year>2002</year>
        </date>
        <date iso-8601-date="2014-08-07" date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2009-08-20" date-type="revised">
          <day>20</day>
          <month>8</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="rotor" document-type="chapter">Rotor Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver Syndrome</related-object>
      <abstract id="rsts.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Rubinstein-Taybi syndrome (RSTS) is characterized by distinctive facial features, broad and often angulated thumbs and great toes, short stature, and moderate to severe intellectual disability. The characteristic craniofacial features are downslanted palpebral fissures, low hanging columella, high palate, grimacing smile, and talon cusps. Prenatal growth is often normal; however, height, weight, and head circumference percentiles rapidly drop in the first few months of life. Obesity may occur in childhood or adolescence. IQ scores range from 25 to 79; average IQ is between 36 and 51. Other variable findings are coloboma, cataract, congenital heart defects, renal abnormalities, and cryptorchidism.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of RSTS is primarily based on clinical features. Chromosome abnormalities are occasionally observed on routine cytogenetic testing. <italic toggle="yes">CREBBP</italic> and <italic toggle="yes">EP300</italic> are the only genes currently known to be associated with RSTS. FISH analysis of <italic toggle="yes">CREBBP</italic> detects microdeletions in approximately 10% of individuals with RSTS. Sequence analysis detects <italic toggle="yes">CREBBP</italic> pathogenic variants in another 40%-50% of affected individuals. Pathogenic variants in <italic toggle="yes">EP300</italic> are identified in approximately 3%-8% of individuals with RSTS.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Early intervention programs, special education, vocational training to address developmental disabilities, and referral to behavioral specialists/psychologists and support groups/resources for family members; standard treatment for eye abnormalities, hearing loss, cardiac defects, cryptorchidism, and sleep apnea; surgical repair of significantly angulated thumbs or duplicated halluces; aggressive management of gastroesophageal reflux and constipation.</p>
          <p><italic toggle="yes">Surveillance</italic>: Monitoring of growth and feeding, especially in the first year of life; annual eye and hearing evaluations; and routine monitoring for cardiac, dental, and renal anomalies.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>RSTS is inherited in an autosomal dominant manner. RSTS typically occurs as the result of a <italic toggle="yes">de novo</italic> pathogenic variant in the family; most individuals represent simplex cases (i.e., the only affected member in a family). In most instances, the parents of an individual with RSTS are not affected. When the parents are clinically unaffected, the empiric recurrence risk for sibs is less than 1%. Individuals with RSTS rarely reproduce. The risk to offspring is 50%. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant or deletion in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rsts.Diagnosis">
        <title>Diagnosis</title>
        <sec id="rsts.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of Rubinstein-Taybi syndrome (RSTS) is established by clinical findings.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Craniofacial appearance</bold> (see <xref ref-type="fig" rid="rsts.F1">Figure 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Downslanted palpebral fissures</p>
            </list-item>
            <list-item>
              <p>Convex nasal ridge with low hanging columella</p>
            </list-item>
            <list-item>
              <p>High palate</p>
            </list-item>
            <list-item>
              <p>Grimacing smile</p>
            </list-item>
            <list-item>
              <p>Talon cusps, an accessory cusp-like structure on the lingual side of the tooth, usually occurring on the maxillary incisors of the permanent dentition</p>
            </list-item>
          </list>
          <p><bold>Other features</bold> (see <xref ref-type="fig" rid="rsts.F2">Figure 2</xref> and <xref ref-type="fig" rid="rsts.F3">Figure 3</xref>)</p>
          <list list-type="bullet">
            <list-item>
              <p>The thumbs and great toes are almost always broad and often angulated.</p>
            </list-item>
            <list-item>
              <p>The distal phalanges of the fingers may appear broad.</p>
            </list-item>
            <list-item>
              <p>The proximal phalanges may be abnormally shaped. Radiographs of the hands and feet in individuals with RSTS are unusual but not necessarily diagnostic.</p>
            </list-item>
            <list-item>
              <p>Almost all males have undescended testes.</p>
            </list-item>
            <list-item>
              <p>Structural abnormalities of the urinary tract are common.</p>
            </list-item>
            <list-item>
              <p>Congenital heart defects of various types occur in approximately one third of individuals with RSTS.</p>
            </list-item>
          </list>
          <p>
            <bold>Growth</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>While prenatal growth is often normal, height, weight, and head circumference percentiles rapidly drop in the first few months of life. Short stature is typical in adulthood.</p>
            </list-item>
            <list-item>
              <p>Obesity may occur in childhood or adolescence and short stature is typical in adulthood.</p>
            </list-item>
          </list>
          <p><bold>Intellectual disability.</bold> The average IQ ranges between 35 and 50; however, developmental outcome varies considerably. A few individuals have been reported with IQs in the 70s.</p>
        </sec>
        <sec id="rsts.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Genes.</bold>
<italic toggle="yes">CREBBP</italic> and <italic toggle="yes">EP300</italic> are the only genes currently known to be associated with Rubinstein-Taybi syndrome (RSTS) [<xref ref-type="bibr" rid="rsts.REF.roelfsema.2005.572">Roelfsema et al 2005</xref>].</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="rsts.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Rubinstein-Taybi Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of Rubenstein-Taybi Syndrome Attributed to Mutation of This Gene</th>
                  <th id="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CREBBP</italic>
                  </td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">50%-60%</td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">FISH&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">EP300</italic>
                  </td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">3%-8%&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">30%&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_rsts.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rsts.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rsts" object-id="rsts.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="rsts.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="rsts.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rsts.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis of all exons and intron/exon boundaries detects pathogenic variants in approximately 40% to 50% of individuals with features of RSTS [<xref ref-type="bibr" rid="rsts.REF.coupry.2002.415">Coupry et al 2002</xref>, <xref ref-type="bibr" rid="rsts.REF.bartsch.2005.485">Bartsch et al 2005</xref>, <xref ref-type="bibr" rid="rsts.REF.bentivegna.2006.77">Bentivegna et al 2006</xref>, <xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al 2008</xref>].</p>
              </fn>
              <fn id="rsts.TF.1.4">
                <label>4. </label>
                <p>The microdeletion frequency in RSTS using FISH analysis is approximately 10% [<xref ref-type="bibr" rid="rsts.REF.petrij.2000.168">Petrij et al 2000</xref>, <xref ref-type="bibr" rid="rsts.REF.petrij.2004">Petrij et al 2004</xref>, <xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al 2008</xref>].</p>
              </fn>
              <fn id="rsts.TF.1.5">
                <label>5. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="rsts.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="rsts.REF.stef.2007.843">Stef et al [2007]</xref> detected deletions in 17 (20.5%) of 83 individuals with typical features of RSTS using array CGH and quantitative multiplex fluorescent-PCR.</p>
              </fn>
              <fn id="rsts.TF.1.7">
                <label>7. </label>
                <p><xref ref-type="bibr" rid="rsts.REF.roelfsema.2005.572">Roelfsema et al [2005]</xref>, <xref ref-type="bibr" rid="rsts.REF.bartholdi.2007.327">Bartholdi et al [2007]</xref>, <xref ref-type="bibr" rid="rsts.REF.negri.2015.148">Negri et al [2015]</xref></p>
              </fn>
              <fn id="rsts.TF.1.8">
                <label>8. </label>
                <p>10/53 individuals with features of RSTS were found to have a deletion or duplication not detected by FISH [<xref ref-type="bibr" rid="rsts.REF.roelfsema.2005.572">Roelfsema et al 2005</xref>].</p>
              </fn>
              <fn id="rsts.TF.1.9">
                <label>9. </label>
                <p>RSTS may be caused by pathogenic variants in another gene or genes in up to 30% of cases [<xref ref-type="bibr" rid="rsts.REF.bartsch.2005.485">Bartsch et al 2005</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="rsts.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirming the diagnosis in a proband.</bold> The diagnosis of RSTS is primarily clinical.</p>
          <p>When the diagnosis is in question or features are atypical or very severe:</p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">CREBBP</italic> can be considered first; followed by duplication/deletion analysis if no pathogenic variant is detected through sequence analysis.</p>
            </list-item>
            <list-item>
              <p>If a pathogenic variant in <italic toggle="yes">CREBBP</italic> is not identified, sequence analysis and/or deletion/duplication analysis of <italic toggle="yes">EP300</italic> may be considered.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="rsts.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rsts.Clinical_Description">
          <title>Clinical Description</title>
          <p>Rubinstein-Taybi syndrome (RSTS) is frequently recognized at birth or in infancy because of the striking facial features and characteristic hand and foot findings. Problems in early life include respiratory difficulties, feeding problems, poor weight gain, recurrent infections, and severe constipation. Moderate intellectual disability is typical.</p>
          <p><bold>Neurologic.</bold> Occasional craniospinal and posterior fossa abnormalities including Chiari malformation, syringomyelia, os odontoideum and cervical cord compression have been reported [<xref ref-type="bibr" rid="rsts.REF.marzuillo.2013.28">Marzuillo et al 2013</xref>].</p>
          <p><bold>Eye.</bold> Eye findings include strabismus, refractory errors, ptosis, nasolacrimal duct obstruction, cataracts, coloboma, nystagmus, glaucoma, and corneal abnormalities. <xref ref-type="bibr" rid="rsts.REF.van_genderen.2000.1177">van Genderen et al [2000]</xref> demonstrated a high frequency of retinal dysfunction on ERG.</p>
          <p><bold>Cardiac.</bold> Approximately one third of affected individuals have a variety of congenital heart defects.</p>
          <p><bold>Genitourinary.</bold> Renal abnormalities are very common and almost all boys have undescended testes.</p>
          <p><bold>Orthopedic.</bold> Orthopedic issues include dislocated patellas, lax joints, spine curvatures, Legg-Perthes disease, slipped capital femoral epiphysis, and cervical vertebral abnormalities [<xref ref-type="bibr" rid="rsts.REF.yamamoto.2005.130">Yamamoto et al 2005</xref>].</p>
          <p><bold>Sleep apnea.</bold> Obstructive sleep apnea is often a considerable problem and may be caused by the combination of a narrow palate, micrognathia, hypotonia, obesity, and easy collapsibility of the laryngeal walls.</p>
          <p><bold>Skin.</bold> Keloids may occur with only minimal trauma to the skin. Pilomatrixomas have been reported [<xref ref-type="bibr" rid="rsts.REF.bayle.2004.607">Bayle et al 2004</xref>].</p>
          <p><bold>Dental.</bold> Dental problems include crowding of teeth, malocclusion, multiple caries, hypodontia, hyperdontia, natal teeth, and talon cusps on the upper incisors of the secondary dentition.</p>
          <p><bold>Tumors.</bold> Tumors reported in individuals with RSTS include meningioma, pilomatrixoma, rhabdomyosarcoma, pheochromocytoma, neuroblastoma, medulloblastoma, oligodendroglioma, leioyosarcoma, seminoma, odontoma, choristoma, and leukemia [<xref ref-type="bibr" rid="rsts.REF.roelfsema.2007.1">Roelfsema &#x00026; Peters 2007</xref>].</p>
          <p><bold>Growth.</bold> Although prenatal growth is usually normal, parameters for height, weight, and head circumference fall below the fifth percentile during infancy. Males often become overweight during childhood while females become overweight during adolescence. Average height for adult males is 153.1 cm and for adult females is 146.7 cm. <xref ref-type="bibr" rid="rsts.REF.stevens.1990.51">Stevens et al [1990]</xref> published growth grids.</p>
          <p><bold>Puberty.</bold> Puberty and sexual development are normal.</p>
          <p><bold>Intellect.</bold> Delayed development is typical in children with RSTS. In one study, the average age of walking was 30 months, first words 25 months, and toilet training 62 months. Speech delay occurs in 90% of children and some remain largely nonverbal.</p>
          <p>The average IQ in one study was 51 and in another study was 36. IQ scores range from 25 to 79. The performance IQ is usually higher than the verbal IQ.</p>
          <p>In one study of adults with RSTS [<xref ref-type="bibr" rid="rsts.REF.stevens.2011.1680">Stevens et al 2011</xref>] families reported a decline in abilities over time in 32%, including decreased social interaction, more limited speech, and worsening stamina and mobility.</p>
          <p><bold>Behavior.</bold> Short attention span, decreased tolerance for noise and crowds, impulsivity, and moodiness are frequently observed. <xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al [2008]</xref> noted frequent autistic behaviors in their study of 93 affected individuals. Other abnormal behaviors included attention problems, hyperactivity, self-injurious behaviors, and aggressive behaviors. Similar concerns regarding behavior were reported in adults with RSTS, with approximately 62% of affected adults reported to have autistic-like behaviors [<xref ref-type="bibr" rid="rsts.REF.stevens.2011.1680">Stevens et al 2011</xref>].</p>
        </sec>
        <sec id="rsts.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al [2008]</xref> studied 93 individuals with RSTS and noted 52 with definitive <italic toggle="yes">CREBBP</italic> pathogenic variants. No significant differences were found in congenital anomalies, tumors, dysmorphic features, or level of intellectual impairment between those with and without pathogenic variants. Growth retardation tended to be greater in the group without pathogenic variants but this was not statistically significant. However, seizures were more common in those with <italic toggle="yes">CREBBP</italic> pathogenic variants. Individuals with large deletions trended toward more severe cognitive impairment and autistic behavior, although this did not reach statistical significance.</p>
          <p>See <xref ref-type="sec" rid="rsts.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref> for a discussion of contiguous gene deletions involving <italic toggle="yes">CREBBP</italic>.</p>
          <p>Mosaic microdeletions have been noted by <xref ref-type="bibr" rid="rsts.REF.gervasini.2007.567">Gervasini et al [2007]</xref> and <xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al [2008]</xref>; these individuals tended to have a less severe phenotype than those with non-mosaic deletions.</p>
          <p>Several individuals have been found to have <italic toggle="yes">EP300</italic> pathogenic variants [<xref ref-type="bibr" rid="rsts.REF.bartholdi.2007.327">Bartholdi et al 2007</xref>, <xref ref-type="bibr" rid="rsts.REF.zimmermann.2007.837">Zimmermann et al 2007</xref>, <xref ref-type="bibr" rid="rsts.REF.bartsch.2010b.181">Bartsch et al 2010b</xref>, <xref ref-type="bibr" rid="rsts.REF.negri.2015.148">Negri et al 2015</xref>]. The features in these persons are said to be milder, particularly the skeletal findings. Some have normal hands and feet. Intellectual development also appears to be less affected, with intelligence ranging from normal to moderate intellectual disability.</p>
        </sec>
        <sec id="rsts.Prevalence">
          <title>Prevalence</title>
          <p><xref ref-type="bibr" rid="rsts.REF.hennekam.1990b.17">Hennekam et al [1990b]</xref> reported a birth prevalence of 1:100,000 to 1:125,000 for RSTS in the Netherlands.</p>
          <p>The majority of individuals reported with RSTS are of European origin; however, some black and Asian individuals with RSTS have been seen. Whether the occurrence of RSTS is lower in non-white populations or the observed difference is the result of other factors is not known.</p>
        </sec>
      </sec>
      <sec id="rsts.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with germline mutation of <italic toggle="yes">CREBBP</italic> and <italic toggle="yes">EP300</italic>.</p>
        <p><bold>Microduplications of <italic toggle="yes">CREBBP</italic></bold> have been reported in several individuals [<xref ref-type="bibr" rid="rsts.REF.marangi.2008.2313">Marangi et al 2008</xref>, <xref ref-type="bibr" rid="rsts.REF.thienpont.2010.155">Thienpont et al 2010</xref>, <xref ref-type="bibr" rid="rsts.REF.mattina.2012.747">Mattina et al 2012</xref>, <xref ref-type="bibr" rid="rsts.REF.demeer.2013.26">Demeer et al 2013</xref>]. The phenotype consists of mild to moderate intellectual disability, normal growth, characteristic facial appearance minor extremity abnormalities and variable other features.</p>
        <p><bold>Deletions of 16p encompassing <italic toggle="yes">CREBBP</italic>.</bold> Although several authors reported no phenotypic differences in individuals with and without 16p deletions encompassing <italic toggle="yes">CREBBP</italic> [<xref ref-type="bibr" rid="rsts.REF.blough.2000.29">Blough et al 2000</xref>, <xref ref-type="bibr" rid="rsts.REF.petrij.2000.168">Petrij et al 2000</xref>], <xref ref-type="bibr" rid="rsts.REF.hennekam.1993.255">Hennekam et al [1993]</xref> found an increased frequency of microcephaly, partial duplication of the hallux, and angulation of the first rays of the hands and feet in those with deletions. No difference in mental functioning was apparent.</p>
        <p><xref ref-type="bibr" rid="rsts.REF.hou.2005.143">Hou [2005]</xref> suggested that disease severity correlated with size of deletion including <italic toggle="yes">CREBBP.</italic>
<xref ref-type="bibr" rid="rsts.REF.bartsch.2006.179">Bartsch et al [2006]</xref> reported three individuals with severe RSTS (including failure to thrive, life-threatening infections, and death in infancy) who had large deletions encompassing <italic toggle="yes">CREBBP</italic> and the contiguous genes <italic toggle="yes">DNASE1</italic> and <italic toggle="yes">TRAP1</italic>. However, <xref ref-type="bibr" rid="rsts.REF.gervasini.2007.567">Gervasini et al [2007]</xref> and <xref ref-type="bibr" rid="rsts.REF.stef.2007.843">Stef et al [2007]</xref> reported affected individuals with deletions of similar scope who did not have a severe phenotype.</p>
      </sec>
      <sec id="rsts.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Given the distinctive facial features and hand and foot abnormalities, the diagnosis of Rubinstein-Taybi syndrome (RSTS) is usually straightforward.</p>
        <p>Broad/angulated thumbs and great toes may be seen in the <italic toggle="yes">FGFR</italic>-related craniosynostosis syndromes (i.e., Pfeiffer syndrome and Apert syndromes), Saethre-Chotzen syndrome, and Greig cephalopolysyndactyly syndrome. The presence of craniosynostosis and the difference in facial features should differentiate these disorders.</p>
        <p>The eight disorders considered as part of the <related-object link-type="booklink" source-id="gene" document-id="craniosynostosis" document-type="chapter"><italic toggle="yes">FGFR</italic>-related craniosynostosis syndromes</related-object> are Pfeiffer syndrome, Apert syndrome, Crouzon syndrome, Beare-Stevenson syndrome, <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans, and <related-object link-type="booklink" source-id="gene" document-id="muenke" document-type="chapter">Muenke syndrome</related-object>
<italic toggle="yes">(FGFR3</italic>-related isolated coronal synostosis). All but Muenke syndrome and <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings; Muenke syndrome and <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis. The diagnosis of Muenke syndrome <italic toggle="yes">(FGFR3</italic>-related coronal synostosis) is based on identification of a pathogenic variant in <italic toggle="yes">FGFR3</italic>. The diagnosis of <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis is based on identification of a pathogenic variant in <italic toggle="yes">FGFR2</italic>. The diagnosis of the other six <italic toggle="yes">FGFR</italic>-related craniosynostoses is based on clinical findings; however, molecular genetic testing of <italic toggle="yes">FGFR1,</italic>
<italic toggle="yes">FGFR2,</italic> and <italic toggle="yes">FGFR3</italic> may be helpful in establishing the diagnosis of these syndromes in questionable cases. <italic toggle="yes">FGFR</italic>-related craniosynostosis is inherited in an autosomal dominant manner.</p>
        <p>Classic <related-object link-type="booklink" source-id="gene" document-id="scs" document-type="chapter">Saethre-Chotzen syndrome</related-object> is characterized by coronal synostosis (unilateral or bilateral), facial asymmetry (particularly in individuals with unicoronal synostosis), ptosis, and characteristic appearance of the ear (small pinna with a prominent crus). Syndactyly of digits two and three of the hand is variably present. Although mild-to-moderate developmental delay and intellectual disability have been reported, normal intelligence is more common. Less common manifestations of Saethre-Chotzen syndrome include short stature, parietal foramina, vertebral fusions, radioulnar synostosis, cleft palate, maxillary hypoplasia, widely spaced eyes, hallux valgus, duplicated distal hallucal phalanx, and congenital heart malformations. The diagnosis of Saethre-Chotzen syndrome is made primarily on clinical findings. Occasionally, affected individuals have a chromosome translocation involving 7p21 or ring chromosome 7. <italic toggle="yes">TWIST1</italic> is the only gene known to be associated with Saethre-Chotzen syndrome. <italic toggle="yes">TWIST1</italic> pathogenic variants are identified in 46%-80% of affected individuals using a combination of deletion/duplication analysis and sequence analysis (exon 1). Saethre-Chotzen syndrome is inherited in an autosomal dominant manner.</p>
        <p>Typical <related-object link-type="booklink" source-id="gene" document-id="gcps" document-type="chapter">Greig cephalopolysyndactyly syndrome</related-object> (GCPS) is characterized by preaxial polydactyly or mixed pre- and postaxial polydactyly, widely spaced eyes, and macrocephaly. Individuals with mild GCPS may have subtle craniofacial findings. The mild end of the GCPS spectrum is a continuum with preaxial polysyndactyly type 4 and crossed polydactyly (preaxial polydactyly of the feet and postaxial polydactyly of the hands plus syndactyly of fingers 3-4 and toes 1-3). Individuals with severe GCPS can have seizures, hydrocephalus, and intellectual disability. The diagnosis of GCPS is based on clinical findings and family history. <italic toggle="yes">GLI3</italic> is the only gene known to be associated with GCPS; <italic toggle="yes">GLI3</italic> alterations (i.e., cytogenetic abnormalities involving <italic toggle="yes">GLI3</italic> or pathogenic variants of <italic toggle="yes">GLI3</italic>) can be identified in more than 75% of typically affected individuals. It is inherited in an autosomal dominant manner.</p>
        <p>Broad thumbs are seen in brachydactyly type D as an isolated finding. Unilateral or bilateral shortening of the distal phalanx of the thumb is present. Inheritance is autosomal dominant.</p>
        <p>The facial features of <related-object link-type="booklink" source-id="gene" document-id="fhs" document-type="chapter">Floating-Harbor syndrome</related-object> can appear similar to RSTS in some individuals. This syndrome is characterized by typical craniofacial features; low birth weight, normal head circumference, and short stature; bone age delay that normalizes between ages six and 12 years; skeletal anomalies (brachydactyly, clubbing, clinodactyly, short thumbs, prominent joints, clavicular abnormalities); severe receptive and expressive language impairment; hypernasality and high-pitched voice; and intellectual disability that is typically mild to moderate. The hand and foot findings are distinct from those of RSTS. Floating-Harbor syndrome is caused by a pathogenic variant in <italic toggle="yes">SRCAP,</italic> which encodes an SNF2-related chromatin-remodeling factor that serves as a coactivator for CREBBP. This likely accounts for the phenotypic overlap with RSTS.</p>
        <p><xref ref-type="bibr" rid="rsts.REF.cotsirilos.1987.85">Cotsirilos et al [1987]</xref> reported a mother and two children with RSTS-like facial and extremity features but with normal intelligence.</p>
        <p>Keipert syndrome is characterized by broad thumbs and halluces but is distinguished by hearing loss and characteristic facial features.</p>
        <p><xref ref-type="bibr" rid="rsts.REF.kargi.2001.166">Kargi et al [2001]</xref> reported an individual with hand and foot findings similar to those of RSTS who also had mild pterygia.</p>
      </sec>
      <sec id="rsts.Management">
        <title>Management</title>
        <sec id="rsts.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Rubinstein-Taybi syndrome (RSTS), the following evaluations are suggested [<xref ref-type="bibr" rid="rsts.REF.wiley.2003.101">Wiley et al 2003</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of growth and plotting of parameters on published syndrome-specific growth charts</p>
            </list-item>
            <list-item>
              <p>Multidisciplinary developmental evaluation including assessment of gross and fine motor skills, speech/language, cognitive abilities, and vocational skills</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation using auditory brain stem evoked response testing (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object> for details of evaluation)</p>
            </list-item>
            <list-item>
              <p>Dental and orthodontic evaluations</p>
            </list-item>
            <list-item>
              <p>Echocardiogram or evaluation by cardiologist for structural heart defects</p>
            </list-item>
            <list-item>
              <p>Assessment for gastroesophageal reflux as warranted</p>
            </list-item>
            <list-item>
              <p>Assessment for constipation</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination</p>
            </list-item>
            <list-item>
              <p>Assessment for presence of cryptorchidism in males</p>
            </list-item>
            <list-item>
              <p>Orthopedic assessment of thumbs and halluces, joints and spine</p>
            </list-item>
            <list-item>
              <p>Evaluation of obstructive sleep apnea if indicated by snoring, particular sleeping posture, wakefulness at night, and excessive sleepiness during the daytime.</p>
            </list-item>
            <list-item>
              <p>Ultrasound of the spinal canal in the neonatal period to screen for tethered cord; MRI of the spinal canal should be performed in older children, if symptomatic.</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="rsts.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Early intervention programs, special education, and vocational training to address developmental disabilities</p>
            </list-item>
            <list-item>
              <p>Standard treatment for refractive errors, strabismus, glaucoma, cataracts, and other eye abnormalities if identified</p>
            </list-item>
            <list-item>
              <p>Standard treatment for hearing loss if identified</p>
            </list-item>
            <list-item>
              <p>Standard treatment for cardiac defects if identified</p>
            </list-item>
            <list-item>
              <p>Aggressive management of gastroesophageal reflux and constipation</p>
            </list-item>
            <list-item>
              <p>Standard treatment for cryptorchidism if identified</p>
            </list-item>
            <list-item>
              <p>Surgical repair of significantly angulated thumbs or duplicated halluces</p>
            </list-item>
            <list-item>
              <p>Appropriate treatment for sleep apnea if identified</p>
            </list-item>
            <list-item>
              <p>Behavior management strategies including referral to a behavioral specialist/psychologist and consideration of medication if needed</p>
            </list-item>
            <list-item>
              <p>Referral of the family to support groups and other resources</p>
            </list-item>
          </list>
        </sec>
        <sec id="rsts.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Individuals with RSTS can be difficult to intubate because of the easy collapsibility of the laryngeal wall. An anesthesiologist comfortable with managing complex pediatric airway problems should therefore administer general anesthesia when needed. Because of these problems, individuals with RSTS may require earlier intubation and later extubation than other individuals undergoing similar procedures.</p>
        </sec>
        <sec id="rsts.Surveillance">
          <title>Surveillance</title>
          <p>Surveillance includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Close monitoring of growth, especially in the first year of life</p>
            </list-item>
            <list-item>
              <p>Annual follow-up evaluation for ophthalmologic abnormalities</p>
            </list-item>
            <list-item>
              <p>Yearly audiologic screens; more frequent evaluation if a history of multiple episodes of otitis media exists</p>
            </list-item>
            <list-item>
              <p>Monitoring as per routine for cardiac or renal anomalies</p>
            </list-item>
            <list-item>
              <p>Regular dental and orthodontic follow up</p>
            </list-item>
          </list>
        </sec>
        <sec id="rsts.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="rsts.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rsts.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="rsts.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rsts.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Rubinstein-Taybi syndrome (RSTS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="rsts.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>RSTS typically occurs as a <italic toggle="yes">de novo</italic> event in the family; most individuals are the only affected member of their families. The parents of most individuals with RSTS are not affected. However, because of variable clinical expression, and reports of mildly affected parents with somatic mosaicism [<xref ref-type="bibr" rid="rsts.REF.chiang.2009.1463">Chiang et al 2009</xref>, <xref ref-type="bibr" rid="rsts.REF.bartsch.2010a.2254">Bartsch et al 2010a</xref>], there is a small chance that a parent with normal intelligence could have a <italic toggle="yes">CREBBP</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband include clinical examination for physical findings associated with RSTS. <xref ref-type="bibr" rid="rsts.REF.bartsch.2010a.2254">Bartsch et al [2010a]</xref> recommended that parents of an individual identified to have a mild <italic toggle="yes">CREBBP</italic> pathogenic variant, such as a missense variant or small in-frame deletion, should undergo molecular testing for the pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the empiric recurrence risk for sibs is less than 1%.</p>
            </list-item>
            <list-item>
              <p>If neither parent of the proband has the <italic toggle="yes">CREBBP</italic> or <italic toggle="yes">EP300</italic> pathogenic variant identified in the proband detectable in their DNA, it is presumed that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant and the risk to the sibs of the proband depends on the probability of germline mosaicism. Germline mosaicism has been reported in the parents of individuals with RSTS [<xref ref-type="bibr" rid="rsts.REF.chiang.2009.1463">Chiang et al 2009</xref>, <xref ref-type="bibr" rid="rsts.REF.tajir.2013.476">Tajir et al 2013</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Parent-to-child transmission of RSTS has been reported [<xref ref-type="bibr" rid="rsts.REF.cotsirilos.1987.85">Cotsirilos et al 1987</xref>, <xref ref-type="bibr" rid="rsts.REF.hennekam.1989.439">Hennekam et al 1989</xref>, <xref ref-type="bibr" rid="rsts.REF.marion.1993.284">Marion et al 1993</xref>, <xref ref-type="bibr" rid="rsts.REF.petrij.2000.168">Petrij et al 2000</xref>, <xref ref-type="bibr" rid="rsts.REF.bartsch.2010a.2254">Bartsch et al 2010a</xref>]. The risk to offspring of an individual with RSTS of inheriting RSTS is 50%.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members of a proband depends on the genetic status of the proband&#x02019;s parents.</p>
        </sec>
        <sec id="rsts.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who have had a child with RSTS.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rsts.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CREBBP</italic> or <italic toggle="yes">EP300</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for Rubinstein-Taybi syndrome are possible options.</p>
        </sec>
      </sec>
      <sec id="rsts.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rsts.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">CREBBP</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">CREBBP</italic> is 154 kb in size and includes 31 transcribed exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004380.2">NM_004380.2</ext-link> ) [<xref ref-type="bibr" rid="rsts.REF.petrij.2000.168">Petrij et al 2000</xref>, <xref ref-type="bibr" rid="rsts.REF.coupry.2002.415">Coupry et al 2002</xref>, <xref ref-type="bibr" rid="rsts.REF.petrij.2004">Petrij et al 2004</xref>]. For a detailed summary of gene and protein information see <related-object source-id="gene" document-id="rsts" object-id="rsts.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Evidence suggests that Rubinstein-Taybi syndrome (RSTS) is caused by haploinsufficiency of <italic toggle="yes">CREBBP</italic> product [<xref ref-type="bibr" rid="rsts.REF.petrij.2001">Petrij et al 2001</xref>]. Microdeletions are seen in approximately 10% of individuals with RSTS [<xref ref-type="bibr" rid="rsts.REF.petrij.2000.168">Petrij et al 2000</xref>, <xref ref-type="bibr" rid="rsts.REF.petrij.2004">Petrij et al 2004</xref>, <xref ref-type="bibr" rid="rsts.REF.schorry.2008.2512">Schorry et al 2008</xref>]. More than 150 pathogenic variants in <italic toggle="yes">CREBBP</italic> are known; they include frameshift, nonsense, splice site and missense variants [<xref ref-type="bibr" rid="rsts.REF.van_belzen.2011">van Belzen et al 2011</xref>].</p>
        <p><bold>Normal gene product.</bold> The CREBB-binding protein (CREBBP) is ubiquitously expressed and is involved in transcriptional coactivation of many different transcription factors. It has intrinsic histone acetyltransferase activity and acts as a scaffold to stabilize additional protein interactions with the transcription complex via chromatin remodeling. It is a mediator of different signaling pathways and can also act as a negative regulator of the cell cycle by repressing the transition from G1 to S phase [<xref ref-type="bibr" rid="rsts.REF.petrij.2001">Petrij et al 2001</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Germline pathogenic variants in <italic toggle="yes">CREBBP</italic> may lead to a truncated CREB-binding protein or one with an amino acid substitution. Pathogenic variants in the HAT domain interfere with the acetylation of histones, which is an important step in transcription activation. Somatic pathogenic variants in <italic toggle="yes">CREBBP</italic> may lead to cancer, as <italic toggle="yes">CREBBP</italic> also functions as a tumor suppressor.</p>
        <p>
          <bold>
            <italic toggle="yes">EP300</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">EP300</italic> is 87.75 kb in length and includes 31 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001429.3">NM_001429.3</ext-link>). For a detailed summary of the gene and protein information see <related-object source-id="gene" document-id="rsts" object-id="rsts.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> RSTS can be caused by pathogenic variants in <italic toggle="yes">EP300</italic> [<xref ref-type="bibr" rid="rsts.REF.roelfsema.2005.572">Roelfsema et al 2005</xref>] including deletions, duplications, and single-nucleotide variants [<xref ref-type="bibr" rid="rsts.REF.negri.2015.148">Negri et al 2015</xref>]. Three of 92 individuals with RSTS studied by <xref ref-type="bibr" rid="rsts.REF.roelfsema.2005.572">Roelfsema et al [2005]</xref> were found to have pathogenic variants in <italic toggle="yes">EP300</italic>. <xref ref-type="bibr" rid="rsts.REF.negri.2015.148">Negri et al [2015]</xref> studied 33 CREBBP-negative patients with RSTS and identified six with pathogenic variants in EP300.</p>
        <p>Pathogenic variants in <italic toggle="yes">EP300</italic> may also lead to cancer, as the gene functions as a tumor suppressor.</p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">EP300</italic> encodes the p300 transcriptional co-activator protein, which shares 63% homology with <italic toggle="yes">CREBBP</italic> at the amino acid level [<xref ref-type="bibr" rid="rsts.REF.iyer.2004.4225">Iyer et al 2004</xref>]. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation [<xref ref-type="bibr" rid="rsts.REF.gayther.2000.300">Gayther et al 2000</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants result in truncated p300 protein or absence of allele expression, which may lead to loss of HAT activity.</p>
        <p>
          <bold>Cancer and Benign Tumors</bold>
        </p>
        <p><italic toggle="yes">CREBBP</italic> and <italic toggle="yes">EP300</italic> participate in various tumor-suppressor pathways and somatic pathogenic variants of these genes occur in a number of malignancies. Somatic translocations t(8;16) (p11;p11.3) involving <italic toggle="yes">CREBBP</italic> and t(8;22)(p11;q13) involving <italic toggle="yes">EP300</italic> [<xref ref-type="bibr" rid="rsts.REF.kitabayashi.2001.89">Kitabayashi et al 2001</xref>] are associated with acute myelogenous leukemia and treatment-related hematologic disorders [<xref ref-type="bibr" rid="rsts.REF.iyer.2004.4225">Iyer et al 2004</xref>]. Some heterozygous <italic toggle="yes">Crebbp</italic>-knockout mice develop lymphomas.</p>
      </sec>
      <sec id="rsts.References">
        <title>References</title>
        <sec id="rsts.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rsts.Literature_Cited.reflist0">
            <ref id="rsts.REF.bartholdi.2007.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartholdi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roelfsema</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedrist</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schinzel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>DJM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetic heterogeneity in Rubinstein-Taybi syndrome: Delineation of the phenotype of the first patients carrying mutations in EP300.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>327</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">17220215</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bartsch.2006.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delicado</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyack</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volleth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haaf</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.</article-title>
                <source>Hum Genet</source>
                <volume>120</volume>
                <fpage>179</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">16783566</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bartsch.2005.485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morlot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiebe</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.</article-title>
                <source>Hum Genet</source>
                <volume>117</volume>
                <fpage>485</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16021471</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bartsch.2010a.2254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempf</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haaf</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zechner</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Inheritance and variable expression in Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010a</year>
                <volume>152A</volume>
                <fpage>2254</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">20684013</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bartsch.2010b.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labont&#x000e9;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zechner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haaf</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010b</year>
                <volume>152A</volume>
                <fpage>181</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20014264</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bayle.2004.607">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bayle</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bazex</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamant</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauque</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durieu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albes</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Multiple perforating and non perforating pilomatricomas in a patient with Churg-Strauss syndrome and Rubinstein-Taybi syndrome.</article-title>
                <source>J Eur Acad Dermatol Venereol</source>
                <volume>18</volume>
                <fpage>607</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15324407</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.bentivegna.2006.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bentivegna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gervasini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castronovo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mottadelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colapietro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atzeri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Divizia</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzielli</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedeschi</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faravelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larizza</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.</article-title>
                <source>BMC Med Genet.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>77</fpage>
                <pub-id pub-id-type="pmid">17052327</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.blough.2000.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blough</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrij</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dauwerse</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milatovich-Cherry</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saal</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Variation in microdeletions of the cyclic AMP-responsive element- binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>90</volume>
                <fpage>29</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">10602114</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.chiang.2009.1463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spector</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>ACH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Somatic and germ-line mosaicism in Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>149A</volume>
                <fpage>1463</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19533794</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.cotsirilos.1987.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cotsirilos</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matalon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Dominant inheritance of a syndrome similar to Rubinstein-Taybi.</article-title>
                <source>Am J Med Genet</source>
                <volume>26</volume>
                <fpage>85</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">3812583</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.coupry.2002.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coupry</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stef</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delrue</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marche</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgelin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taine</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arveiler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>415</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12070251</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.demeer.2013.26">
              <mixed-citation publication-type="journal"><person-group><name name-style="western"><surname>Demeer</surname><given-names>B</given-names></name><name name-style="western"><surname>Andrieux</surname><given-names>J</given-names></name><name name-style="western"><surname>Receveur</surname><given-names>A</given-names></name><name name-style="western"><surname>Morin</surname><given-names>G</given-names></name><name name-style="western"><surname>Petit</surname><given-names>F</given-names></name><name name-style="western"><surname>Julia</surname><given-names>S</given-names></name><name name-style="western"><surname>Plessis</surname><given-names>G</given-names></name><name name-style="western"><surname>Martin-Coignard</surname><given-names>D</given-names></name><name name-style="western"><surname>Delobel</surname><given-names>B</given-names></name><name name-style="western"><surname>Firth</surname><given-names>HV</given-names></name><name name-style="western"><surname>Thuresson</surname><given-names>AC</given-names></name></person-group>Lanco dosen S, Sjors K, Le caignec C, Devriendt K, Mathieu-Dramard M<year>2013</year><article-title>Duplication of 16p13.3 and the CREBBP gene: confirmation of the phenotype.</article-title><source>Eur J Med Genet</source><volume>56</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">23063576</pub-id></mixed-citation>
            </ref>
            <ref id="rsts.REF.gayther.2000.300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gayther</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batley</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linger</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bannister</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorpe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chin</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daigo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowter</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delhanty</surname>
                    <given-names>JDA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponder</surname>
                    <given-names>BAJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kouzarides</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldas</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations truncating the EP300 acetylase in human cancers.</article-title>
                <source>Nature Genet</source>
                <volume>24</volume>
                <fpage>300</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10700188</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.gervasini.2007.567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gervasini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castronovo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentivegna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mottadelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faravelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovannucci-Uzielli</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pessagno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucci-Cordisco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larizza</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breaks.</article-title>
                <source>Genomics</source>
                <volume>90</volume>
                <fpage>567</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">17855048</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.hennekam.1989.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lommen</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strengers</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Spijker</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen-Kokx</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Rubinstein-Taybi syndrome in a mother and son.</article-title>
                <source>Eur J Pediatr</source>
                <volume>148</volume>
                <fpage>439</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">2920750</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.hennekam.1993.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voshart-van Heeren</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariman</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beersum</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Boogaard</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.</article-title>
                <source>Am J Hum Genet</source>
                <volume>52</volume>
                <fpage>255</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">8430692</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.hennekam.1990b.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Boogaard</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibbles</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Spijker</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>1990b</year>
                <article-title>Rubinstein-Taybi syndrome in The Netherlands.</article-title>
                <source>Am J Med Genet Suppl</source>
                <volume>6</volume>
                <fpage>17</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">2118773</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.hou.2005.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Rubinstein-Taybi syndrome: clinical and molecular cytogenetic studies.</article-title>
                <source>Acta Paediatr Taiwan</source>
                <volume>46</volume>
                <fpage>143</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16231561</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.iyer.2004.4225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iyer</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozdag</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldas</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>p300/CBP and cancer.</article-title>
                <source>Oncogene</source>
                <volume>23</volume>
                <fpage>4225</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15156177</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.kargi.2001.166">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kargi</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balci</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akoz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kargi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdogan</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A case with some clinical findings overlapping to Rubinstein-Taybi, Rubinstein-Taybi-like syndrome or multiple pterygium syndrome: coincidental findings or a new entity?</article-title>
                <source>Turk J Pediatr</source>
                <volume>43</volume>
                <fpage>166</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11432500</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.kitabayashi.2001.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kitabayashi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosoda</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakazu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohki</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.</article-title>
                <source>Leukemia</source>
                <volume>15</volume>
                <fpage>89</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11243405</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.marangi.2008.2313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marangi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leuzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orteschi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimaldi</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecce</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zollino</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>2313</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18688873</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.marion.1993.284">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marion</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karasik</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Apparent dominant transmission of the Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>46</volume>
                <fpage>284</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8488872</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.marzuillo.2013.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marzuillo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grandone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cozzolino</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Festa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luongo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Giudice</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrone</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome, GH deficiency, Arnold Chiari malformation and pituitary hypoplasia.</article-title>
                <source>BMC Med Genet.</source>
                <year>2013</year>
                <volume>14</volume>
                <fpage>28</fpage>
                <pub-id pub-id-type="pmid">23432975</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.mattina.2012.747">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mattina</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palumbo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stallone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulvirenti</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dio</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavone</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavone</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Interstitial 16p13.3 microduplication: case report and review of genotype-phenotype correlation.</article-title>
                <source>Eur J Med Genet</source>
                <volume>55</volume>
                <fpage>747</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">23032921</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.negri.2015.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Negri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colapietro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forzano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Monica</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusconi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Consonni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caffi</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spena</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larizza</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gervasini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene.</article-title>
                <source>Clin Genet.</source>
                <year>2015</year>
                <volume>87</volume>
                <fpage>148</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">24476420</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.petrij.2004">
              <mixed-citation publication-type="book">Petrij F, Breuning MH, Hennekam RCM, Giles RH. CBP: Rubinstein-Taybi syndrome. In: Epstein, Erickson, Wynshaw-Boris, eds. <italic toggle="yes">The Molecular Basis of Clinical Disorders of Morphogenesis</italic>. 1 ed. New York: Oxford University Press; 2004:728-46.</mixed-citation>
            </ref>
            <ref id="rsts.REF.petrij.2000.168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petrij</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dauwerse</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blough</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giles</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Smagt</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallerstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maaswinkel-Mooy</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haeringen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saal</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.</article-title>
                <source>J Med Genet</source>
                <volume>37</volume>
                <fpage>168</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">10699051</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.petrij.2001">
              <mixed-citation publication-type="webpage">Petrij F, Giles RH, Breuning MH, Hennekam RCM. Rubinstein-Taybi syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. 8 ed. Chap 248. New York, NY: McGraw-Hill. 2001:6167-82. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. Accessed 5-3-16.</mixed-citation>
            </ref>
            <ref id="rsts.REF.roelfsema.2005.572">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roelfsema</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariyurek</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholdi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedrist</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacino</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Dunnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>572</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15706485</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.roelfsema.2007.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roelfsema</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>DJM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Rubinstein-Taybi syndrome: clinical and molecular overview.</article-title>
                <source>Expert Rev Mol Med</source>
                <volume>9</volume>
                <fpage>1</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17942008</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.schorry.2008.2512">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schorry</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keddache</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanphear</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srodulski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blough-Pfau</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Genotype-phenotype correlations in Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>2512</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18792986</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.stef.2007.843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stef</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mardirossian</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delrue</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgelin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marche</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupry</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arveiler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>15</volume>
                <fpage>843</fpage>
                <lpage>847</lpage>
                <pub-id pub-id-type="pmid">17473832</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.stevens.1990.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blackburn</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Growth in the Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet Suppl</source>
                <volume>6</volume>
                <fpage>51</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2118779</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.stevens.2011.1680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouncey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knowles</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Adults with Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>155A</volume>
                <fpage>1680</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21671385</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.tajir.2013.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tajir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fergelot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lancelot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elalaoui</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arveiler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sefiani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Germline mosaicism in Rubinstein-Taybi syndrome.</article-title>
                <source>Gene</source>
                <volume>518</volume>
                <fpage>476</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23352794</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.thienpont.2010.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thienpont</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bena</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breckpot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philip</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menten</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scalais</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salamone</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fong</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kussmann</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grange</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorski</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zahir</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Duplications of the critical Rubinstein-Taybi deletion region on chromosome 16p13.3 cause a novel recognizable syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>47</volume>
                <fpage>155</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">19833603</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.van_belzen.2011">
              <mixed-citation publication-type="other">van Belzen M, Bartsch O, Lacombe D, Peters DJ, Hennekam RC. Rubinstein-Taybi syndrome (CREBBP, EP300). Eur J Hum Genet. 2011;19:preceding 118-20.</mixed-citation>
            </ref>
            <ref id="rsts.REF.van_genderen.2000.1177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Genderen</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinds</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riemslag</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>84</volume>
                <fpage>1177</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">11004107</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.wiley.2003.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swayne</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanphear</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Rubinstein-Taybi syndrome medical guidelines.</article-title>
                <source>Am J Med Genet A</source>
                <volume>119A</volume>
                <fpage>101</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12749047</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.yamamoto.2005.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurosawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuzumi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aida</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Congenital anomaly of cervical vertebrae is a major complication of Rubinstein-Taybi syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>135</volume>
                <fpage>130</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15832359</pub-id>
              </element-citation>
            </ref>
            <ref id="rsts.REF.zimmermann.2007.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acosta</surname>
                    <given-names>AMBF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>15</volume>
                <fpage>837</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">17299436</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rsts.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rsts.Author_Notes">
          <title>Author Notes</title>
          <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cincinnatichildrens.org/service/r/rubinstein-taybi/default/">The Rubinstein-Taybi Syndrome Program</ext-link> at Cincinnati Children&#x02019;s is one of the country&#x02019;s leading programs for the care of children with RTS and provides expert confirmation of diagnosis as well as the latest treatments and support.</p>
        </sec>
        <sec id="rsts.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 August 2009 (cd) Revision: sequence analysis, deletion/duplication analysis, and prenatal diagnosis available clinically for <italic toggle="yes">EP300</italic> mutations</p>
            </list-item>
            <list-item>
              <p>16 April 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 June 2007 (cd) Revision: sequence analysis and mutation scanning available clinically</p>
            </list-item>
            <list-item>
              <p>2 October 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 December 2005 (cs) Revision: <italic toggle="yes">EP300</italic> mutations found to cause some cases of RSTS</p>
            </list-item>
            <list-item>
              <p>13 September 2004 (cd) Revision: testing</p>
            </list-item>
            <list-item>
              <p>22 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 August 2002 (tk,me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 April 2002 (cs) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="rsts.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Typical facial appearance in RSTS. Note arched brows, downslanted palpebral fissures, low handing columella, and grimacing smile.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rsts-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="rsts.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>A. Broad terminal phalanges B. Broad, radially deviated thumbs</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rsts-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="rsts.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Broad, partially duplicated great toes</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rsts-Image003" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
